Biotechnology company focused on developing improved treatments for thrombotic diseases
TargED Biopharmaceutical has raised €39M across 1 funding round from 8 investors, most recently a Series A round in Feb 2022. Based in Utrecht, Netherlands; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-02-22 | Series A |
| €39M |
| Andera Partners,Curie Capital,First Venture,Fund plus,Hadean Ventures,Inkef Capital+2 more |
| View deal → |
